Hytrin

Terazosin, the active ingredient in Hytrin, is an alpha‑1 adrenergic receptor antagonist presented as an oral tablet for oral use. It is employed to lower high blood pressure and to improve urinary flow in men with an enlarged prostate.

GNH USA supplies Hytrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality for global healthcare providers. The company adheres to stringent quality‑assurance protocols and maintains active registrations across EU and other major markets.

Hytrin (Terazosin) acts on the alpha‑1 adrenergic pathway to manage vascular and prostatic conditions. - Hypertension: reduces systemic vascular resistance to lower blood pressure. - Benign prostatic hyperplasia: relaxes smooth muscle in the prostate and bladder neck to improve urine flow.

Terazosin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: especially after the first dose or when standing quickly. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Nasal congestion: stuffy or runny nose.

Serious or Rare Side Effects: - Orthostatic hypotension: marked drop in blood pressure upon standing, leading to fainting. - Priapism: prolonged, painful erection requiring immediate medical attention.

Before initiating therapy, consider the following safety measures. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess renal function: dose adjustment may be needed in severe impairment. - Review cardiac history: caution in patients with recent myocardial infarction. - Avoid abrupt position changes: rise slowly to reduce dizziness. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Terazosin can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors: may cause severe hypotension. - Other antihypertensives: additive blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance orthostatic hypotension. - CYP3A4 inhibitors (e.g., ketoconazole): can increase terazosin plasma levels. - Alcohol: may potentiate dizziness and hypotension.